fingolimod hydrochloride has been researched along with manganese dioxide in 1 studies
Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (manganese dioxide) | Trials (manganese dioxide) | Recent Studies (post-2010) (manganese dioxide) |
---|---|---|---|---|---|
2,771 | 157 | 2,062 | 675 | 1 | 469 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Chen, Q; Chu, Y; Guo, Q; Jiang, C; Li, C; Li, X; Liu, P; Luo, Y; Ning, T; Song, H; Su, B; Sun, T; Wang, Y; You, H; Zhang, T; Zhang, Y; Zhao, Z; Zhou, W; Zhou, Z | 1 |
1 other study(ies) available for fingolimod hydrochloride and manganese dioxide
Article | Year |
---|---|
Macrophage-Disguised Manganese Dioxide Nanoparticles for Neuroprotection by Reducing Oxidative Stress and Modulating Inflammatory Microenvironment in Acute Ischemic Stroke.
Topics: Animals; Cell Line, Tumor; Cellular Microenvironment; Fingolimod Hydrochloride; Humans; Hydrogen Peroxide; Inflammation; Ischemic Stroke; Lysosomes; Macrophages; Manganese Compounds; Nanoparticles; Nanospheres; Neurons; Neuroprotection; Oxidative Stress; Oxides; Oxygen; Primary Cell Culture; Rats; Reperfusion Injury | 2021 |